Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 2

Mutation Research - DNA Repair

Volumn 407, Issue 3, 1998, Pages 217-226

  Friedberg, Errol C ^a   Meira, Lisiane B ^a   Cheo L, David ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

DNA; Mouse strain; Targeted mutation

Indexed keywords

ARTICLE; DATA BASE; DNA DAMAGE; DNA DETERMINATION; DNA REPAIR; GENE MUTATION; GENETIC ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; DATABASES, FACTUAL; DNA DAMAGE; GENOME; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MUTATION;

EID: 0032102885     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(97)00066-9     Document Type: Article

References (47)

1. [1] E.C. Friedberg, L.B. Meira, D.L. Cheo, Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 1, Mutation Res. 383 (1997) 183-188.
2. [2] H. Gu, J.D. Marth, P.C. Orban, H. Mossmann, K. Rajewsky, Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting, Science 265 (1994) 103-106.
3. [3] S. Xanthoudakis, R.J. Smeyne, J.D. Wallace, T. Curran, The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 8919-8923.
4. [4] D.J. Bentley, J. Selfridge, J.K. Millar, K. Samuel, N. Hole, J.D. Ansell, D.W. Melton, DNA ligase I is required for fetal liver development but is not essential for mammalian cell viability, Nat. Genet. 13 (1996) 489-491.
5. [5] B.P. Engelward, G. Weeda, M.D. Wyatt, J.L.M. Brockhof, J. DeWit, I. Donker, J.M. Allen, B. Gold, J.H.J. Hoeijmakers, L.D. Samson, Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase, Proc. Natl Acad. Sci. U.S.A. 94 (1997) 13087-13092.
6. 4-ethanocytosine or 8-oxyguanine, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12869-12874.
7. [7] J. McWhir, J. Selfridge, D.J. Harrison, S. Squires, D.W. Melton, Mice with DNA repair gene (ERCC1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning, Nat. Genet. 5 (1993) 217-223.
8. [8] G. Weeda, I. Donker, J. de Wit, H. Morreau, C.J. Visser, A.L. Nigg, R. Janssens, H. van Steeg, P.M. Dortant, D. Bootsma, J.H.J. Hoeijmakers, Disruption of the mouse ERCC1 endonuclease results in a novel DNA repair syndrome with growth failure, nuclear abnormalities in liver and kidney and signs of premature senescence, Curr. Biol. 7 (1997) 427-439.
9. [9] A. de Vries, C.Th.M. van Ostrom, F.M.A. Hofhuis, P.M. Dortant, R.J.W. Berg, F.R. de Gruijl, P.W. Wester, C.F. van Kreijl, P.J.A. Capel, H. van Steeg, S.J. Verbeek, Increased susceptibility to ultraviolet-B and carcinogenesis in mice lacking the DNA repair gene XPA, Nature 377 (1995) 169-173.
10. [10] H. Nakane, S. Takeuchi, S. Yuba, M. Saijo, Y. Nakatsu, H. Murai, Y. Nakatsuru, T. Ishikawa, S. Hirota, Y. Kitamura, Y. Kato, Y. Tsunoda, H. Miyauchi, T. Horio, T. Tokunaga, T. Matsunaga, O. Nikaido, Y. Nishimune, Y. Okada, K. Tanaka, High incidence of ultraviolet-B or chemical carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene, Nature 377 (1995) 165-168.
11. [11] A.T. Sands, A. Abuin, A. Sanchez, C.J. Conti, A. Bradley, High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC, Nature 377 (1995) 162-165.
12. [12] D.L. Cheo, H.J.T. Ruven, L.B. Meira, R.E. Hammer, D.K. Burns, N.J. Tappe, A.A. van Zeeland, L.H.F. Mullenders, E.C. Friedberg, Characterization of defective nucleotide excision repair in XPC mutant mice generated by targeted gene replacement, Mutat. Res. 374 (1997) 1-9.
13. [13] D.L. Cheo, L.B. Meira, R.E. Hammer, D.K. Burns, A.T.B. Doughty, E.C. Friedberg, Synergistic interactions between XPC and p53 mutations in double mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer, Curr. Biol. 6 (1996) 691-1694.
14. [14] L.B. Meira, D.L. Cheo, A. Reis, R.E. Hammer, D.K. Burns, E.C. Friedberg, Genetic interaction between HAP1 (Ref-1) and p53, Nat. Genet. 17 (1997) 145.
15. [15] G. Weeda, I. Donker, J.L.M. Brockhof, J. de Wit, J.H.J. Hoeijmakers, Lethal and viable targeted mutations in the basal transcription/DNA repair helicase XPB: a mouse model for the human repair disorder xeroderma pigmentosum, manuscript in preparation.
16. [16] J. de Boer, I. Donker, J. de Wit, J.H.J. Hoeijmakers, G. Weeda, Disruption of the XPD DNA repair/transcription gene results in pre-implantation embryonic lethality, Cancer Res., in press.
17. [17] J. de Boer, J. de Wit, P. Visser, H. Morreau, M. Duran, J.H.J. Hoeijmakers, G. Weeda, A mouse model for the basal transcription/DNA repair disorder trichothiodystrophy, manuscript in preparation.
18. [18] Y.-N. Harada, N. Shiomi, M. Ikawa, M. Okabe, S. Hirota, Y. Kitamura, M. Kitagawa, M. Koike, T. Shiomi, Post-natal growth failure, a short life span and dysfunction of the small intestines in knock out mice with inactivated XPG alleles that involve nucleotide excision repair, manuscript in preparation.
19. [19] G.T.J. van der Horst, H. van Steeg, R.J.W. Berg, A.J. van Gool, J. de Wit, G. Weeda, H. Morreau, R.B. Beems, C.F. van Kreijl, F.R. de Gruijl, D. Bootsma, J.H.J. Hoeijmakers, Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition, Cell 89 (1997) 425-435.
20. [20] T. Tsuzuki, K. Sakumi, A. Shiraishi, H. Kawate, H. Igarashi, T. Iwakuma, Y. Tominaga, S. Zhang, S. Shimizu, T. Ishikawa, K. Nakamura, K. Nakao, M. Katsuki, M. Sekiguchi, Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent, Carcinogenesis 17 (1996) 1215-1220.
21. [21] S.M. Baker, C.E. Bronner, L. Zhang, A.W. Plug, M. Robatzek, G. Warren, E.A. Elliott, J. Yu, T. Ashley, N. Arnheim, R.A. Flavell, R.M. Liskay, Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis, Cell 82 (1995) 309-319.
22. [22] N. de Wind, M. Dekker, A. Berns, M. Radman, H. te Riele, Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyper-recombination, and predisposition to cancer, Cell 82 (1995) 321-330.
23. [23] A.M. Reitmar, R. Schmits, A. Ewel, B. Bapat, M. Redston, A. Mitri, P. Waterhouse, H.-W. Mittrucker, A. Wakeham, B. Liu, A. Thomason, H. Griesser, S. Gallinger, W.G. Ballhausen, R. Fishel, T.W. Mak, MSH2 deficient mice are viable and susceptible to lymphoid tumors, Nat. Genet. 11 (1995) 64-70.
24. [24] A. Cranston, T. Bocker, A. Reitmar, J. Palazzo, T. Wilson, T. Mak, R. Fischel, Female embryonic lethality in mice nullizygous for both Msh2 and p53, Nat. Genet. 17 (1997) 114-118.
25. [25] W. Edelman, K. Yang, A. Umar, J. Heyer, K. Lau, K. Fan, W. Liedtke, P.E. Cohen, M.F. Kane, J.R. Lipford, N. Yu, G.F. Crouse, J.W. Pollard, T. Kunkel, M. Lipkin, R. Kolodner, R. Kucherlapati, Mutation in the mismatch repair gene Msh6 causes cancer susceptibility, Cell 91 (1997) 467-477.
26. [26] W. Edelmann, P.E. Cohen, M. Kane, K. Lau, B. Morrow, S. Bennett, A. Umar, T. Kunkel, G. Cattoretti, R. Chaganti, J.W. Pollard, R.D. Kolodner, R. Kucherlapati, Meiotic pachytene arrest in MLH1-deficient mice, Cell 85 (1996) 1125-1134.
27. [27] L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery Jr., J.S. Butel, A. Bradley, Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors, Nature 356 (1992) 215-221.
28. [28] T. Tsukada, Y. Tomooka, S. Takai, Y. Ueda, S.-I. Nishikawa, T. Yagi, T. Tokunaga, N. Takeda, Y. Suda, S. Abe, I. Matsuo, Y. Ikawa, S. Aizawa, Enhanced proliferative potential in culture of cells from p53-deficient mice, Oncogene 8 (1993) 3313-3322.
29. [29] T. Jacks, L. Remington, B.O. Williams, E.M. Schmitt, S. Halachmi, R.T. Bronson, R.A. Weinberg, Tumor spectrum analysis in p53-mutant mice, Curr. Biol. 4 (1994) 1-7.
30. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control, Cell 82 (1995) 675-684.
31. [31] C. Barlow, S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J.N. Crawley, T. Ried, D. Tagle, A. Wynshaw-Boris, ATM-deficient mice: a paradigm of ataxia telangiectasia, Cell 86 (1996) 159-171.
32. [32] M. Serrano, H.-W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, R.A. DePinho, Role of the INK4a locus in tumor suppression and cell mortality, Cell 85 (1996) 27-37.
33. [33] R.S. Tebbs, J.J. Meneses, M. Flannery, L.H. Thompson, J.E. Cleaver, R.A. Pederson, Knockout of the mouse Xrcc1 base excision repair gene causes early embryonic lethality, manuscript submitted.
34. [34] C. Zhu, M.A. Bogue, D.-S. Lim, P. Hasty, D.B. Roth, Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates, Cell 86 (1996) 379-389.
35. [35] A. Nussenzweig, C. Chen, V. de Costa Soares, M. Sanchez, K. Sokol, M.C. Nussenzweig, G.C. Li, Requirement for Ku80 in growth and immunoglobulin V(D)J recombination, Nature 382 (1996) 551-555.
36. [36] Z.-Q. Wang, B. Auer, L. Stingl, H. Berghammer, D. Haidacher, M. Schweiger, E.F. Wagner, Mice lacking AD-PRT and poly(ADP)-ribosylation develop normally but are susceptible to skin disease, Genes Dev. 9 (1995) 509-520.
37. [37] de Murcia, J.M.C. Niedergang, C. Trucco, M. Ricoul, B. Dutrillaux, M. Mark, F.J. Oliver, M. Masson, A. Dierich, M. LeMeur, C. Walztinger, P. Chambon, G. de Murcia, Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7303-7307.
38. [38] H.P. Roest, J. van Klaveren, J. de Wit, C.G. van Gurp, M.H.M. Koken, M. Vermey, J.H. van Roijen, J.W. Hoogerbrugge, J.T.M. Vreeburg, W.M. Baarends, D. Bootsma, J.A. Grootegoed, J.H.J. Hoeijmakers, Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification, Cell 86 (1996) 799-810.
39. [39] T. Tsuzuki, Y. Fujii, K. Sakumi, Y. Tominaga, K. Nakao, M. Sekiguchi, A. Matsushiro, Y. Yoshimura, T. Morita, Targeted disruption of the Rad51 gene leads to lethality in embryonic mice, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6236-6240.
40. [40] D.-S. Lim, P. Hasty, A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53, Mol. Cell. Biol. 16 (1996) 7133-7143.
41. [41] J. Essers, R.W. Hendriks, S.M.A. Swagemakers, C. Troelstra, J. de Wit, D. Bootsma, J.H.J. Hoeijmakers, R. Kanaar, Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination, Cell 89 (1997) 195-204.
42. [42] S.K. Sharan, M. Morimatsu, U. Albrecht, D.-S. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty, A. Bradley, Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2, Nature 386 (1997) 804-810.
43. [43] T. Ludwig, D.L. Chapman, V.E. Papaioannou, A. Efstratiadis, Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos, Genes Dev. 11 (1997) 1226-1241.
44. [44] A. Suzuki, J.L. de la Pompa, R. Hakem, A. Elia, R. Yoshida, R. Mo et al., Brca2 is required for embryonic cellular proliferation in the mouse, Genes Dev. 11 (1997) 1242-1252.
45. [45] F. Connor, D. Bertwistle, P.J. Mee, G.M. Ross, S. Swift, E. Grigorieva, V.L.J. Tybulewicz, A. Ashworth, Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation, Nat. Genet. 17 (1997) 423-430.
46. [46] M. Chen, D.J. Tomkins, W. Auerbach, C. McKerlie, H. Youssoufian, L. Liu, O. Gan, M. Carreau, A. Auerbach, T. Groves, C.J. Guidos, M.H. Freedman, J. Cross, D.H. Percy, J.E. Dick, A.L. Joyner, M. Buchwald, Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anemia, Nat. Genet. 12 (1996) 448-451.
47. [47] M.A. Whitney, G. Royle, M.J. Low, M.A. Kelly, M.K. Axthelm, C. Reifsteck, S. Olson, R.E. Braun, M.C. Heinrich, R.K. Rathbun, G.C. Bagby, M. Grompe, Germ cell defects and hemopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene, Blood 88 (1996) 49-58.